Neurodegeneration in type 2 diabetes: Alzheimer's as a case study
Open Access
- 14 March 2020
- journal article
- review article
- Published by Wiley in Brain and Behavior
- Vol. 10 (5) , e01577
Abstract
Introduction: Rigorous research in the last few years has shown that in addition to the classical mechanism of neurodegeneration, certain unconventional mechanisms may also lead to neurodegenerative disease. One of them is a widely studied metabolic disorder: type 2 diabetes mellitus (T2DM). We now have a clear understanding of glucose‐mediated neurodegeneration, mostly from studies in Alzheimer's disease (AD) models. AD is recognized to be significantly associated with hyperglycemia, even earning the term “type 3 diabetes.” Here, we review first the pathophysiology of AD, both from the perspective of classical protein accumulation, as well as the newer T2DM‐dependent mechanisms supported by findings from patients with T2DM. Secondly, we review the different pathways through which neurodegeneration is aggravated in hyperglycemic conditions taking AD as a case study. Finally, some of the current advances in AD management as a result of recent research developments in metabolic disorders‐driven neurodegeneration are also discussed.Methods: Relevant literatures found from PubMed search were reviewed.Results: Apart from the known causes of AD, type 2 diabetes opens a new window to the AD pathology in several ways. It is a bidirectional interaction, of which, the molecular and signaling mechanisms are recently studied. This is our attempt to connect all of them to draw a complete mechanistic explanation for the neurodegeneration in T2DM. Refer to Figure 3.Conclusion: The perspective of AD as a classical neurodegenerative disease is changing, and it is now being looked at from a zoomed‐out perspective. The correlation between T2DM and AD is something observed and studied extensively. It is promising to know that there are certain advances in AD management following these studies.Keywords
Funding Information
- Indian Institute of Science Education and Research (IISER), Tirupati
- DST-SERB
This publication has 119 references indexed in Scilit:
- Exenatide and the treatment of patients with Parkinson’s diseaseJournal of Clinical Investigation, 2013
- Amyloid Precursor Protein Processing and Alzheimer's DiseaseAnnual Review of Neuroscience, 2011
- Actions of β-Amyloid Protein on Human Neurons Are Expressed through the Amylin ReceptorThe American Journal of Pathology, 2011
- Role of Reactive Oxygen Species in the Progression of Type 2 Diabetes and AtherosclerosisMediators of Inflammation, 2010
- The Final Frontier: How Does Diabetes Affect the Brain?Diabetes, 2010
- Mechanisms of tau-induced neurodegenerationActa Neuropathologica, 2009
- Alzheimer's disease and vascular dementia in developing countries: prevalence, management, and risk factorsThe Lancet Neurology, 2008
- Influence of Hyperglycemia on Oxidative Stress and Matrix Metalloproteinase-9 Activation After Focal Cerebral Ischemia/Reperfusion in RatsStroke, 2007
- Physiological roles for amyloid β peptidesThe Journal of Physiology, 2006
- Loss of autophagy in the central nervous system causes neurodegeneration in miceNature, 2006